Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Retained Earnings

₹356.42B

Quarterly · Period ending: · INR

RDY logo

RDY Retained Earnings

Latest reported₹356.42B INR
RDY Quarterly Retained Earnings · INR (₹1.07B → ₹356.42B)
High-resolution chart · PNG

RDY retained earnings history

Quarterly · INR. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock Retained Earnings — Quarterly (INR)
Period endingRetained Earnings (INR)
356,419,000,000
345,015,664,000
349,783,000,000
337,683,000,000
329,971,000,000
315,793,000,000
299,350,000,000
285,180,000,000
279,264,000,000
265,257,000,000
3,029,283,021
238,226,000,000
230,020,000,000
215,593,000,000
2,498,658,285
2,386,748,820
2,378,220,266
2,318,865,061
2,353,029,804
2,260,873,665
2,176,254,540
2,133,976,167
2,082,800,150
2,066,386,554
1,987,186,066
1,906,736,504
1,913,820,966
142,302,000,000
135,288,000,000
128,646,000,000
124,301,000,000
119,449,000,000
118,414,000,000
113,865,000,000
110,843,000,000
107,499,000,000
108,642,000,000
108,224,000,000
105,099,000,000
100,398,000,000
100,838,000,000
99,550,000,000
98,804,000,000
93,012,000,000
89,900,000,000
83,643,000,000
78,454,000,000
72,709,000,000
70,555,000,000
65,051,000,000
57,887,000,000
51,919,000,000
48,213,000,000
44,815,000,000
39,314,000,000
35,746,000,000
34,748,000,000
31,599,000,000
28,373,000,000
23,458,000,000
22,807,000,000
20,391,000,000
22,986,000,000
20,255,000,000
20,131,000,000
18,035,000,000
16,398,000,000
21,690,000,000
0
18,305,000,000
28,082,000,000
25,636,732,000
25,322,546,000
24,031,880,000
23,024,785,568
23,805,357,445
21,956,902,896
20,138,763,965
16,882,867,196
14,908,500,734
12,621,238,595
11,230,728,492
11,433,562,731
10,813,326,417
10,356,608,488
10,009,300,789
9,704,565,023
10,488,486,322
10,400,137,593
10,251,844,304
10,067,579,808
9,497,711,589
9,020,465,522
8,298,863,447
7,671,414,756
6,960,676,509
6,201,261,270
4,981,021,143
3,937,783,043
3,048,262,698
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.